Hanan Qasem

This study investigates how tumor LDHC expression affects immune responses in breast cancer, finding that LDHC knockdown enhances T cell activation and reduces immunosuppressive factors and checkpoint molecule expression.

This paper evaluates four cell-penetrating peptides for delivering LDHC siRNA to TNBC cells, finding that two show effective LDHC knockdown and tumor reduction in zebrafish models.